Articles
Vaccination Referrals from ED Paediatric Antimicrobial Guidance Children’s Services Resolution and Escalation Protocol Blunt Chest Wall Trauma/Rib Fractures Information for Parents Carers of Children Having Investigations in Relation to Unexplained Injuries + Consent form Bruising and Injuries in Babies and Children – Parents Leaflet Multi-Agency Protocol for Injuries to Non-Mobile Children Flowchart for children attending Galloway Community Hospital (GCH) for NAI Follow Up Skeletal Survey Flowchart for children attending DGRI for NAI Follow-Up Skeletal Survey Cognitive Function Conscious Level Kidney Biopsy Complications Parenteral Iron for Non-HD CKD Patients Fracture Management Guidelines (Paediatric) Fracture Management Guidelines (Adult) Management of Hypertension in Acute Stroke Prescribing for CAU Patients Still in ED Hypothermia Deactivation of Implantable Cardioverter Defibrillator Myeloma Croup Care Of Burns In Scotland (COBIS) Paediatric Guidance Management of Epistaxis Sore Throat Differential Diagnosis Dizziness Differential Diagnosis Peritonsillar Abscess/Quinsy Acute Tonsillitis Acute Mastoiditis Otitis Media Otitis Externa Extravasation of IV Amiodarone WoS Paediatric Drooling and Aspiration Guideline Palliative Care – How to Refer Eating Disorders Stroke Care Warfarin Anticoagulation for AF, DVT and PE Molnupiravir MyPsych Foundation Doctors Toolkit Paediatric Febrile Neutropenia Guidance PAEDIATRIC HYPOGLYCAEMIA MANAGEMENT in NON DIABETIC CHILDREN   Paediatric Diabetic Ketoacidosis (DKA) Guideline Child Protection Policies and Procedures (D&G) Management of Acute Behavioural Challenges in Adolescents and Young People presenting to Secondary Care Cancer of Unknown Primary Patients Returning from Interventional Cardiac Procedure Treatment of Malaria Discharging Patients on High Dose Steroids Sotrovimab Paediatric Ketone Correction Guideline Insulin Correction Factor Table (Paediatrics) Management of uncomplicated Henoch-Schonlein Purpura (HSP) in under 16s Management of Hypoglycaemia in Children with Type 1 Diabetes Newly diagnosed diabetic – not in DKA (Walking wounded) Proton Pump Inhibitor Guideline for Neonatal and Paediatrics Stroke – Post Thrombolysis Neonatal Guidelines Gentamicin Prescribing (Paediatrics) Management of Anaphylaxis (Paediatrics) Management of Prolonged Seizures (Convulsive Status Epilepticus) in Children Bronchiolitis Acute Wheeze or Asthma in Paediatrics Conscious Proning Covid-19 Basics Remdesivir Thromboprophylaxis Identifying Patients in the Highest Risk Groups Steroids for Patients with Covid-19 Infection IL-6 Inhibitors – Tocilizumab or Sarilumab Baricitinib Paxlovid (Nirmatrelvir/Ritonavir) Influenza A Inhalers for Adults with Asthma Standard Operating Procedure for AMU Trigger Finger/Thumb Osteoarthritis of the Hand/Thumb Mallet Finger Ganglion Dupuytren’s Contracture De Quervain’s Tenosynovitis Carpal Tunnel Syndrome Prescribing Advice on Admission – Clozapine Prescribing Advice on Admission – Methadone/Buprenorphine Prescribing Advice on Admission – Corticosteroids Prescribing Advice on Admission – Items Not Prescribed by GP Prescribing Advice on Admission – Patients on Chemotherapy Regimes Prescribing Advice on Admission – Medication for Parkinson’s Disease Prescribing Advice on Admission – Insulin Prescribing Advice on Admission Medical Emergencies in Eating Disorders (MEED) Gentamicin & Vancomycin HIV Testing Guidelines Metabolic Syndrome Associated Fatty Liver Disease (MAFLD) Greener Inhaler Prescribing C4 Predischarge Beds Handover Safe and Secure Handling of Medicines Blood Glucose & Steroids IV Fentanyl & Morphine for Acute Pain in Adults Assessment & Management of Acute Pain Hospitalised and Has Coronavirus19 Infection (No suspected Viral Pneumonia Syndrome) Hospitalised Due to Coronavirus19 with Likely Viral Pneumonia Bi-Level NIV S/T Guidelines for CCU Phase Bi-Level NIV S/T Guidelines for ED Phase Adults With Incapacity Premenstrual Syndrome Pelvic USS Boarding Coeliac diagnosis pathway (Adults) Voice clinic Ear Wax Dermatology Squamous Cell Carcinoma (SCC) Malignant Melanoma Basal Cell Carcinoma (BCC) Nipple Discharge Early Cancer Diagnostic Clinic (ECDC) Genetics Referrals Breast Infections Breast Pain Primary Care Prescribing Guidelines Emergency Department Anaesthetics and Chronic Pain Team Respiratory Referrals Chronic Cough Pathway GP Clinical Handbook Test Paediatric Bronchiolitis Early Cancer Diagnosis Clinic (ECDC) Obstetrics & Gynaecology/Medicine Admission Agreement Idiopathic Intrancranial Hypertension Urology Out of Hours Urology Out of Hours Sengstaken/Minnesota Tube for Bleeding Varices Eradication of Helicobacter pylori Transfer from Galloway Community Hospital Repatriation of Patients from Tertiary Hospitals THROMBOPROPHYLAXIS IN PREGNANCY – Appendix 1, Risk factors THROMBOPROPHYLAXIS IN PREGNANCY – Appendix 3, Postnatal assessment & management THROMBOPROPHYLAXIS IN PREGNANCY – Appendix 4 THROMBOPROPHYLAXIS IN PREGNANCY – Appendix 2, Management of women with previous VTE THROMBOPROPHYLAXIS IN PREGNANCY, LABOUR AND THE PUERPERIUM Orthopaedic VTE Risk Assessment Sodium Glucose Transporter 2 Inhibitors (SGLT2i) Cardiology Referrals Vascular Referrals ‘Watershed’ Conditions Myasthenia Gravis Gentamicin in Renal Replacement Therapy Vancomycin in Renal Replacement Therapy REDMAP Poster Realistic Conversations Summary Plan for Deteriorating Health Treatment Escalation Plans Ambulatory Care for Blood and/or Iron Infusion Principles for Light Touch Patients – B2 Clostridiodes difficile Infection Post Astra Zeneca Vaccine Headache Blood Culture Rhabdomyolysis Analgesia Acute Appendicitis Small Bowel Obstruction Elective Admission – Colorectal Surgery Trauma Admissions Post-operative Care Gallstone Disease Vasopressors and Inotropes/Chronotropes Shock Elective Admission – ERCP Elective Admission – Orthopaedics Laxatives Fat Embolism Compartment Syndrome Surgical Post-operative Complications Stoma Diverticular Disease High Dose Steroid Pre-Treatment Checklist Acute Surgical Admissions Level 1 CCU Medical Area Acute Oncology STEMI Thrombolysis Protocol Haemolytic Anaemia Conversion Charts Anticipatory ‘As Required’ Medications Syringe Driver Chart Scottish Palliative Care Guidelines Covid-19 Sick Day Rules for Patients with Primary Adrenal Insufficiency Diabetic Retinopathy Coming Off Benzodiazepines and “Z” Drugs Dental Abscess Facial Trauma – Mandibular Fractures Facial Trauma – Orbital Fractures Facial Trauma – Zygoma Platelet Transfusion Death Certification Parenteral Iron in Adults >18 Years OPAT SBAR (Complex Infections) Mental Health Liaison Team Referrals STEMI Admitting Patients with Tracheostomy/Laryngectomy to DGRI Emergency Laryngectomy Management Emergency Tracheostomy Management Safe Transfer of Patients with Tracheostomy/Laryngectomy within DGRI Other Tracheostomy Documents Systemic Anticancer Therapy Toxicity Haemodialysis Medication Prescribing Breaking Bad News by Telephone End of Life Diabetes Care Adrenal Insufficiency Serotonin Syndrome DGRI Referrals Confirmation of Death Neuroleptic Malignant Syndrome Pulmonary Embolism Deep Vein Thrombosis of Lower Extremities Exacerbation of COPD Contrast Associated AKI Acute Kidney Injury – Introduction Paracetamol Hypertensive Emergencies Staphylococcus aureus Bacteraemia (SAB) Rate Control in AF Common Scenarios Acute Severe Ulcerative Colitis IV Fluid Prescription in Adults Chronic Obstructive Pulmonary Disease Legionnaires Disease Septic Arthritis Guillain-Barré Syndrome Back Pain Anaesthetics – Unscheduled Procedures Requests Hyperglycaemia & Steroids Variable Rate Insulin Infusion Decompensated Liver Disease Fast Atrial Fibrillation – ACP Hyperkalaemia Contraindications to MRI Magnetic Resonance Imaging Bleeding with Other Antithrombotics In-patient Hyperglycaemia Management Anaemia (Management) – ACP Suspected NSTEMI – ACP Guidance on Chaperones Compulsory Admission and Treatment Radiology Immediate Discharge Letter Alcohol Withdrawal Fentanyl Patches in the Last Days of Life Care in the Last Days of Life Low Molecular Weight Heparin Interstitial Lung Disease Haematinic Testing Thromboprophylaxis for Non-Covid Patients Lung Cancer Osteoporosis Heart Failure Fluid Replacement in AKI Death & The Procurator Fiscal Thrombophilia Screening Neutropenic Sepsis Acute Vertigo Aortic Dissection Antithrombotics in Hip Fracture Transient Global Amnesia Hypomagnesaemia Hypophosphataemia Oxygen Therapy Falls – ACP Falls Acute Asthma Oncology Contact Details & General Advice Reversal of Warfarin Lumbar Puncture, Antiplatelet & Anticoagulant Drugs Antithrombotics & Surgery Non ST Elevation MI (NSTEMI) Suspected Acute Coronary Syndrome Antibiotics and the Kidney Acute Upper GI Bleeding (AUGIB) Pericardiocentesis Pleural Effusion Spontaneous Pneumothorax Acute Diarrhoea Iron Deficiency Anaemia Hyperthyroidism Gout Giant Cell Arteritis Pacemakers Clinical Suspicion PE – ACP Community Acquired Pneumonia (CAP) Management of Urinary Symptoms Management of Acute Kidney Injury SSRI Poisoning Immobility Autopsies Indications for Echocardiography Bradycardia Suspected Meningitis Hypernatraemia Diarrhoea – ACP Suspected Meningitis – ACP Blood Transfusion Brain Tumours Newer Antidiabetic Drugs Parkinson’s Disease Major Haemorrhage Protocols (DGRI & GCH) Major Haemorrhage Stroke Thrombolysis Heart Failure – ACP Suspected Anaphylaxis Anaphylaxis – ACP The AMB Score – ACP Transient Loss of Consciousness (TLOC) – ACP Bell’s Palsy – ACP Suspected Sepsis Lumbar Puncture Hypokalaemia Gentamicin Dosing Transient Loss of Consciousness Urinary Tract Infection Urethral Catheterisation Vancomycin Dosing Hyponatraemia Narrow Complex Tachycardia Hypocalcaemia New Onset Type 1 Diabetes – ACP Paracentesis for Tense Ascites – ACP Idiopathic Intracranial Hypertension – ACP Other Funny Turns Hypoglycaemia Hypoglycaemia – ACP Management of Transfusion Reactions Hypercalcaemia Haematemesis – ACP Anti-Platelet Therapy in Coronary Heart Disease Unfractionated Heparin Infusion Anaemia (Investigation) – ACP Delirium Suspected Seizure – ACP Headache – ACP Community Acquired Pneumonia – ACP Cellulitis Dyspepsia Management of Acute AF Rhythm Control in AF Atrial Fibrillation Renal Transplants Massive Pulmonary Embolism Head and Neck Injury Diabetic Ketoacidosis Switching from VRII Insulin Pumps Diabetes Mellitus Aspirin Digoxin Poisoning Tricyclic Antidepressants Opiates Benzodiazepines Gut Decontamination Deliberate Self Harm Acute Liver Failure Asymptomatic Raised Transaminases (ALT & AST) Nutritional Support in Adults Refeeding Syndrome Parenteral Nutrition Crohn’s Disease Acute Pancreatitis Abdominal Aortic Aneurysms Malignant Spinal Cord Compression Post Splenectomy Sepsis Ascites in Cirrhosis Alcohol Related Liver Disease Hepatitis C Symptom Control Suspected Variceal Bleeding Severe Headache Status Epilepsy in Adults Lower Gastrointestinal Bleeding Functional & Social Assessment Breathlessness with Abnormal CXR Polymyalgia Rheumatica Rheumatoid Arthritis Ureteric Colic & Renal Stones Intravascular Catheter Related Blood Stream Infection Care of Vascular Access Urinary Incontinence Peritoneal Dialysis Related Peritonitis The First Seizure Hypertension Ventricular Tachycardia Cardiogenic Shock Complicating Acute Coronary Syndrome Telemetry The Diabetic Foot Subcutaneous Insulin Diabetes and Acute Coronary Syndrome Hyperosmolar Hyperglycaemic State Multiple Sclerosis Coma
 
 
In this section Close
Home | Articles | Care of the Elderly | Parkinson’s Disease

Parkinson’s Disease

Last updated 4th March 2024

Overview

  1. Chronic neurodegenerative disorder affecting basal ganglia and resulting from loss of dopamine and dopaminergic neurones
  2. Incidence increases with age affecting 2% population over 80
  3. More common in men
  4. Presents with bradykinesia plus at least one of rigidity, tremor, postural instability
  5. Diagnosis is essentially clinical versus Essential Tremor and Cerebrovascular Parkinsons

Bradykinesia

  1. Patients describe a “weakness” or “tiredness
  2. Reduced dexterity esp buttons, shoelaces, writing, coins
  3. Test finger tapping and heel tapping
  4. Gait freezing or festination
  5. Lack of facial expression

Tremor

  1. Pill rolling, rest tremor, 4-5Hz, unilateral initially
  2. Rarely affects head, can affect legs, lips, jaw and tongue
  3. Worse with anxiety, emotion, stress and cold
  4. Tremor dominant PD often has a better prognosis

Differential Diagnosis Tremor

  1. The main differential is with essential tremor – the distinction is not always easy
    ETPD
    TremorUsually bilateralUsually unilateral initially
    Body PartHands, head, voiceHands, legs, lips, jaw, tongue but not head
    Family HistoryPositive 50%Often negative
    AlcoholMay improve tremorMinimal effect

Rigidity

  1. Increased resistance to passive movement
  2. Unilateral, becomes asymmetric
  3. Cogwheel = tremor and tone
  4. Causes stiffness and pain

Postural Instability

  1. A later feature of the disease
  2. Can elicit using the Pull Test – Subject stands with eyes open and feet shoulder width apart. Examiner stands behind, instructs subject to do whatever it takes to not fall and says that examiner will catch them if they do fall. The examiner gives a sudden, brief backward pull to the shoulders with sufficient force to cause the subject to have to regain their balance. Test is positive if subject takes several steps backwards and needs to be supported to prevent fall.

SPECT Scan

  1. Uses an iodine containing compound to identify presynaptic dopaminergic deficit.
  2. Helps to distinguish between PD/Parkinsonian Plus and Essential Tremor or Cerebrovascular Parkinsonism but doesn’t distinguish between PD and Parkinsons Plus.
  3. Only available in larger centres and expertise is required to interpret scans

Levodopa

  1. Levodopa, the precursor of dopamine, is combined with decarboxyylase inhibitor to prevent breakdown of L-dopa to dopamine outside the brain
  2. First choice in patients with bradykinesia
  3. Quicker action than dopamine agonists
  4. Co-careldopa (Sinemet) = levodopa + carbidopa and is available in tablets or suspension to allow NG administration. 7 day shelf life.
  5. Co-beneldopa (Madopar) = levodopa + benserazide is available as capsules and dispersible tablets but is too gritty for NG tube
  6. Different strengths available:12.5/50, 10/100, 25/100, 25/250
  7. Start low and titrate slowly eg 12.5/50 tid with meals then after approx 2 weeks increase gradually to 25/100 tid
  8. Titrate to lowest dose with the therapeutic response
  9. Initially given with food to reduce nausea, then on an empty stomach in later stages due to delayed gastric emptying
  10. Side effects include nausea, dyskinesias, dystonia, end of dose deterioration, unpredictable on/off effects, postural hypotension, confusion, visual hallucinations, agitation, delusions. Use Domperidone if nauseated
  11. Controlled release preparations no longer advised as poor absorption and poor bioavailability

Dopamine Receptor Agonists

  • First line in younger patients as can delay the need for levodopa
  • Often used as adjunct to levopopa in older patients
  • Commonly used are Ropinirole, Pramipexole (both oral), Rotigotine (patch)
  • Apomorphine available as subcut infusion.
  • Pergolide and Cabergoline withdrawn due to side effects
  • Beware confusion between salt and base eg Pramipexole 0.125mg salt/ 88microgram base
  • Treatments can be given once a day orally or by patch
  • Start with low dose and titrate up
  • Fewer motor fluctuations than levopopa
  • Side effects can be significant and include impulsive behaviour eg gambling – PD team complete an impulsive and compulsive behaviour tool with each patient and partner, ask them to sign it and send a copy to the GP Other side effects are daytime sleepiness, hallucinations, nausea, ankle oedema
  • Withdrawal can be similar to cocaine withdrawal with anxiety, panic attacks, sweating, nausea

Other Drugs

  • MAOB inhibitors eg Selegiline and Rasagiline. Inhibit breakdown of dopamine within the brain. Can be used to delay the need for Levodopa. May be mood enhancing. Side effects include dizziness, abdominal pain, dry mouth, nausea, stomach upset, trouble sleeping, and headache. Risk of serotonergic syndrome with SSRIs and SNRIs.
  • Anticholinergics – went out of fashion because of high risk of side effects but starting to be used again for younger patients with tremor eg Trihexyphenidyl Can be addictive and take months to stop
  • Amantidine – antiviral, known to increase dopamine release and have other effects which have initially seen it used for monotherapy but later to help settle dyskinesias
  • COMT (catechol-O-methyltransferase) inhibitors – Entacapone and Tolcapone (rarely used because of liver toxicity). Prolong the Levodopa effect therefore useful for patients with end of dose wearing off. Stanek is a useful polypil containing levodopa/carbidopa/entacapone in ratio 50/12.5/200. Side effects include confusion and Orange urine.

Drug Rules in Hospital

  1. Never stop drugs suddenly or even miss a dose as risk of Parkinsonian Neuroleptic Malignant Syndrome (NMS)
  2. Patients must be prescribed and given their PD drugs at the times they take it at home – not to fit in with ward rounds
  3. Encourage patients to bring their own meds in for formulation consistency and med rec.
  4. HEPMA – use free form boxes for dosing
  5. Try to give regular release levodopa rather than controlled release as poor absorption and low bioavailablity
  6. Avoid Haloperidol for agitation – Lorazepam is drug of choice if drug required but try to talk down with family first.
  7. If swallowing issues or NBM give co-careldopa suspension via NG or switch to Rotigotine Patch 4mg/24hrs. Patches stocked in surgical HDU

Parkinsonian Neuroleptic Malignant Syndrome

  1. If a patient is NBM for approx 24 hours or longer they are at high risk of Parkinsonian-hyperpyrexia syndrome, very similar to NMS
  2. Features include rigidity, fever, reduced conscious level, autonomic instability and raised CK
  3. Complications are AKI, aspiration pneumonia, DVT/PE, DIC.

Nausea and Vomiting

  1. Rx lowest effective dose Domperidone orally or rectally – NB risk of QT prologation if >60yrs or >30mg daily
  2. Safe alternatives are cyclizine orally/IM/IV or ondansetron
  3. Avoid metoclopramide and prochlorperazine in PD
  4. Refer PD team asap

Confusion/Hallucination/Agitation

  1. Try to avoid prescribing if possible but if necessary Rx Lorazepam – can cause paradoxical increase in agitation so monitor closely
  2. Avoid haloperidol or chlorpromazine in PD, and particularly in Lewy Body Disease
  3. Refer PD team asap

Dizziness and Falls

  1. Check lying/standing BP
  2. Review need for drugs that cause postural hypotension
  3. Note that PD itself and PD drugs can cause postural hypotension
  4. Refer PD team asap

Subcutaneous Apomorphine for Infusion

  1. All patients admitted to hospital on Apomorphine, a dopamine agonist given by SC infusion, should continue on Apomorphine and be referred to PD team asap.
  2. Apomorphine is not suitable for emergency administration in a drug naive patient and should only be started by a member of the PD team

Drug Induced Parkinsonism

  1. Commonly neuroleptics, metoclopramide, prochlorperazine, fluphenazine, cinnarizine.
  2. Lithium, valproate and amiodarone can cause tremor only without other Parkinsonian features.
  3. Recovery from drug induced Parkinsonism can take up to a year.

Parkinson’s Plus

  1. Parkinson’s plus postural hypotension, cerebellar and/or autonomic system involvement = Multiple System Atrophy
  2. Parkinson’s plus early dementia and hallucinations = Lewy Body Disease
  3. Parkinson’s plus failure of vertical, esp downward, gaze or early postural instability with falls = Progressive Supranuclear Palsy
  4. Parkinson’s plus syndromes associated with poor response to levodopa and shortened life expectancy

Parkinson’s and Dementia

  1. Dementia is more common in patients with PD. There are two forms:
  2. Parkinson’s dementia is diagnosed when someone already has the motor symptoms of Parkinson’s and has had them for some time.
  3. Dementia with Lewy bodies is diagnosed when someone has the symptoms of dementia either before or at the same time as they develop Parkinson’s.

Prognosis

  1. Outlook is variable and related to age at onset
  2. If PD starts before 70 then usually progressive and likely to shorten lifespan
  3. Onset after 70 less likely to shorten life but may become severe

Referrals

  1. Please refer before starting treatment as signs can change and patients often not keen to stop treatment once started
  2. Dr Shona Donaldson will see new patients, email [email protected]
  3. Dr Mignon Gerrits can also be contacted, email [email protected]
  4. Laura Chapman, PD Nurse Specialist 33909, is automatically notified of any PD patient’s hospital admission and will try to see on ward to ensure meds are correct etc. However if having problems with a patient’s management and Laura hasn’t seen them, contact Dr Donaldson.

Links

Content by Dr Shona Donaldson